fig3

Figure 3. Classification and regression trees evaluation of glutathione recycling capacity (GRC) as predictive tool for patients treated with TCH (A) or TCHP (B) chemotherapy. As seen in A, GRC has no added value for risk stratification. In contrast, when breast cancer patients are first separated into young/older age, the GRC can aid in the identification of individuals at high risk for moderate-to-severe delayed nausea